The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings

The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology

1993 • 14,121 citations

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1982 • 10,605 citations

Health Measurement Scales: A Practical Guide to Their Development and Use

1989 • 9,482 citations

Reporting results of cancer treatment

1981 • 7,916 citations

Probabilistic Models for Some Intelligence and Attainment Tests

1961 • 6,793 citations

Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale

2001 • 5,030 citations

Health Measurement Scales

2008 • 2,521 citations

Health Measurement Scales: A Practical Guide to Their Development and Use

2015 • 2,500 citations

CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment

2003 • 2,458 citations

Effect Sizes for Interpreting Changes in Health Status

1989 • 2,352 citations

The Rasch measurement model in rheumatology: What is it and why use it? When should it be applied, and what should one look for in a Rasch paper?

2007 • 1,426 citations

Karnofsky performance status revisited: reliability, validity, and guidelines.

1984 • 1,412 citations

Comparisons of Five Health Status Instruments for Orthopedic Evaluation

1990 • 927 citations

Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995–99: results of the EUROCARE-4 study

2007 • 806 citations

Quality of life research within the EORTC—the EORTC QLQ-C30

2002 • 710 citations

The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: The QLQ-CIPN20

2005 • 480 citations

Sensitivity and accuracy of the visual analogue scale: a psycho‐ physical classroom experiment.

1978 • 468 citations

Application of Rasch Analysis in the Development and Application of Quality of Life Instruments

2004 • 425 citations

Total neuropathy score

1999 • 423 citations

Quality of life: what is it? How should it be measured?

1988 • 346 citations

Rasch-built Overall Disability Scale (R-ODS) for immune-mediated peripheral neuropathies

2011 • 312 citations

Measuring vibration threshold with a graduated tuning fork in normal aging and in patients with polyneuropathy

1998 • 268 citations

Chemotherapy-Induced Peripheral Neurotoxicity assessment: A critical revision of the currently available tools

2010 • 259 citations

A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA

2010 • 244 citations

The Total Neuropathy Score as an assessment tool for grading the course of chemotherapy‐induced peripheral neurotoxicity: comparison with the National Cancer Institute‐Common Toxicity Scale

2007 • 235 citations

Comprehensive Criteria for Assessing Therapy-Induced Toxicity

1990 • 234 citations

THE INTERNATIONAL CLASSIFICATION OF FUNCTIONING, DISABILITY AND HEALTH - ICF

2013 • 232 citations

Pitfalls in grading severity of chemotherapy-induced peripheral neuropathy

1998 • 203 citations

Patient-reported outcomes: Assessment and current perspectives of the guidelines of the Food and Drug Administration and the reflection paper of the European Medicines Agency

2008 • 194 citations

Psychometric evaluation of a new sensory scale in immune-mediated polyneuropathies

2000 • 193 citations

Patient perspectives on breast cancer treatment side effects and the prospective surveillance model for physical rehabilitation for women with breast cancer

2012 • 191 citations

Evaluating measurement responsiveness.

1995 • 185 citations

Grading of chemotherapy-induced peripheral neuropathy

2000 • 163 citations

Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials

2010 • 153 citations

Assessment of Quality of Life After Gastrectomy Using EORTC QLQ‐C30 and STO22

2010 • 125 citations

Assessing the Reliability of Two Toxicity Scales: Implications for Interpreting Toxicity Data

1993 • 121 citations

Chemotherapy-induced peripheral neurotoxicity in the era of pharmacogenomics

2011 • 114 citations

The relationship between numbness, tingling, and shooting/burning pain in patients with chemotherapy-induced peripheral neuropathy (CIPN) as measured by the EORTC QLQ-CIPN20 instrument, N06CA

2011 • 112 citations

The taxanes: toxicity and quality of life considerations in advanced ovarian cancer

2003 • 96 citations

Responsiveness and minimal important score differences in quality‐of‐life questionnaires: a comparison of the EORTC QLQ‐C30 cancer‐specific questionnaire to the generic utility questionnaires EQ‐5D and 15D in patients with multiple myeloma

2011 • 92 citations

Revising two-point discrimination assessment in normal aging and in patients with polyneuropathies

2008 • 82 citations

Long-term sequelae after cancer therapy

2004 • 71 citations

Reliability and responsiveness of a graduated tuning fork in immune mediated polyneuropathies

2000 • 67 citations

Outcome measures in immune‐mediated neuropathies: the need to standardize their use and to understand the clinimetric essentials

2008 • 48 citations

Quality of life in patients receiving treatment for gynecologic malignancies: Special considerations for patient care

2003 • 41 citations

Evaluating Health-Related Quality of Life in Cancer Clinical Trials: The National Cancer Institute of Canada Clinical Trials Group Experience

2007 • 40 citations

CI‐PERINOMS: chemotherapy‐induced peripheral neuropathy outcome measures study

2009 • 31 citations

Scoring based on item response theory did not alter the measurement ability of EORTC QLQ-C30 scales

2005 • 12 citations

Cited By (0)

No citing papers found in database